MANAGEMENT OF FIRST TRIMESTER OF PREGNANCY WITH AYURVEDIC RASAYANA THERAPY AND MICRONIZED PROGESTERONE.

MANAGEMENT OF FIRST TRIMESTER PREGNANCY WITH RASAYANA THERAPY AND MICRONIZED PROGESTERONEâ?? A COMPARATIVE CONTROLLED CLINICAL TRIAL

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2020/12/030135

Enrollment

Registered

2020-12-30

Start date

Unknown

Completion date

Unknown

Last updated

2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: O092- Supervision of pregnancy with other poor reproductive or obstetric history

Interventions

Intervention1: RASAYAN GRANULES: Rasayana granules will be given orally in the dose of 10gm twice a day with Godugdha in morning and evening time in empty stomach for 2 months. Control Intervention1:

Eligibility

Inclusion criteria

Inclusion criteria: 1. Married females of age between 20 - 40 years in first trimester of pregnancy having Hb > 7gm/dl. 2. Pregnancy confirmed by urine pregnancy test and ultrasonography. 3. All the UPT +ve cases between 6-8 weeks of pregnancy with or without these conditions:Primigravida/ multigravida with BOH, pregnancy after infertility, H/o threatened abortion, H/o habitual abortion, H/o blighted ovum, delayed fetal pole development, choriodecidual hemorrhage, IUFD, still birth, congenital deformity, previous preterm birth.

Exclusion criteria

Exclusion criteria: 1. Married females of age 40 years age in first trimester of pregnancy. 2. Women in 2nd trimester or more trimester of pregnancy. Multigravida without BOH. 3. Women with severe systemic disease. 4. Diagnosed cases of disorders of reproductive tract like tuberculosis, carcinoma, and uterine fibroid and STDs. Incompetent Os and congenital deformities of uterus.

Design outcomes

Primary

Measure	Time frame
It is expected that the trial drug will help in achieving healthy progeny without any trouble shootingTimepoint: 9-12 WEEKS AND 20 WEEKS OF PREGNANCY	—

Secondary

Measure	Time frame
Drug may have effect in reducing the minor ailments and complications of first trimester of pregnancy.Timepoint: 9-12 WEEKS AND 20 WEEKS OF PREGNANCY	—

Countries

India

Contacts

Public ContactPROF LAXMIPRIYA DEI

IPGT AND RA,JAMNAGAR

deilaxmipriya@yahoo.com9228198366

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026